Deep Learning Model for Predicting Lung Adenocarcinoma Recurrence from Whole Slide Images

Author:

Su Ziyu1ORCID,Afzaal Usman1ORCID,Niu Shuo2ORCID,de Toro Margarita Munoz3,Xing Fei4ORCID,Ruiz Jimmy5,Gurcan Metin N.1ORCID,Li Wencheng2,Niazi M. Khalid Khan1ORCID

Affiliation:

1. Center for Artificial Intelligence Research, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA

2. Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA

3. Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA

4. Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA

5. Department of Hematology and Oncology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA

Abstract

Lung cancer is the leading cause of cancer-related death in the United States. Lung adenocarcinoma (LUAD) is one of the most common subtypes of lung cancer that can be treated with resection. While resection can be curative, there is a significant risk of recurrence, which necessitates close monitoring and additional treatment planning. Traditionally, microscopic evaluation of tumor grading in resected specimens is a standard pathologic practice that informs subsequent therapy and patient management. However, this approach is labor-intensive and subject to inter-observer variability. To address the challenge of accurately predicting recurrence, we propose a deep learning-based model to predict the 5-year recurrence of LUAD in patients following surgical resection. In our model, we introduce an innovative dual-attention architecture that significantly enhances computational efficiency. Our model demonstrates excellent performance in recurrent risk stratification, achieving a hazard ratio of 2.29 (95% CI: 1.69–3.09, p < 0.005), which outperforms several existing deep learning methods. This study contributes to ongoing efforts to use deep learning models for automatically learning histologic patterns from whole slide images (WSIs) and predicting LUAD recurrence risk, thereby improving the accuracy and efficiency of treatment decision making.

Funder

National Cancer Institute

National Institute of Biomedical Imaging and Bioengineering

Alliance Clinical Trials in Oncology, and Wake Forest University School of Medicine Department of Pathology Clinical Pilot Grant

Publisher

MDPI AG

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3